...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: a $6 sell order drops ZEN 96% !

This is when you transfer a gazillion ZEN shares to a TFSA.

Share
New Message
Please login to post a reply